Literature DB >> 31643024

Retraction Note to: Identification of CYP3A4 as the primary cytochrome P450 responsible for the metabolism of tandospirone by human liver microsomes.

Kiyohi Natsui1, Yoshiko Mizuno2, Naoko Tani2, Masashi Yabuki2, Setsuko Komuro2.   

Abstract

The publisher has retracted this article [1] because it is an incorrect version that was published in error: Figures 5 and 6 are missing.

Entities:  

Year:  2019        PMID： 31643024     DOI： 10.1007/s13318-019-00585-5

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN： 0378-7966            Impact factor:   2.441


  2 in total

1.  Identification of CYP3A4 as the primary cytochrome P450 responsible for the metabolism of tandospirone by human liver microsomes.

Authors:  Kiyohi Natsui; Yoshiko Mizuno; Naoko Tani; Masashi Yabuki; Setsuko Komuro
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2007 Oct-Dec       Impact factor: 2.441

2.  Identification of CYP3A4 as the primary cytochrome P450 responsible for the metabolism of tandospirone by human liver microsomes.

Authors:  Kiyohi Natsui; Yoshiko Mizuno; Naoko Tani; Masashi Yabuki; Setsuko Komuro
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2007 Jul-Sep       Impact factor: 2.441
  2 in total
  1 in total

1.  The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular carcinoma tissues.

Authors:  Yu-Yan Pang; Jian-Di Li; Li Gao; Xia Yang; Yi-Wu Dang; Ze-Feng Lai; Li-Min Liu; Jie Yang; Hua-Yu Wu; Rong-Quan He; Zhi-Guang Huang; Dan-Dan Xiong; Li-Hua Yang; Lin Shi; Wei-Jia Mo; Deng Tang; Hui-Ping Lu; Gang Chen
Journal:  Cancer Med       Date:  2020-09-15       Impact factor: 4.452
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.